← All trials
NCT05772234
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 17, 2023
- Primary completion
- Oct 31, 2024
- Completion date
- Nov 30, 2024
- First posted
- Mar 16, 2023
- Last posted
- Nov 21, 2023
- Enrollment
- 1066
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Changhai HospitalLead sponsor
- Changhai HospitalOverall official - principal investigator
- Changhai HospitalReponsible party - principal investigator
- First People's Hospital of HangzhouCollaborator
- LanZhou UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Ningxia Medical UniversityCollaborator
- Shandong UniversityCollaborator
- Changhai HospitalSponsor investigator
- Chinese Academy of Medical SciencesCollaborator
- Changhai HospitalOfficial
- Central South UniversityCollaborator
- Yunnan University of Traditional Chinese MedicineCollaborator
- Baotou Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.